Dr. Clement C. Zai is a staff scientist in Molecular Science at the Centre for Addiction and Mental Health (CAMH). He is also an associate professor in the Department of Psychiatry at the University of Toronto. He received his PhD in Medical Science at the University of Toronto, examining genes for schizophrenia and tardive dyskinesia. He later received his MPH in Epidemiology from Harvard School of Public Health. He studied the genetics of suicide on a postdoctoral fellowship from the American Foundation for Suicide Prevention and a NARSAD Young Investigator Award from the Brain and Behavior Research Foundation. He has been conducting several pharmacogenetic studies in patients with schizophrenia, with a particular focus on the tardive dyskinesia side effects induced by antipsychotic drugs.
Dr. Clement C. Zai is a staff scientist in Molecular Science at the Centre for Addiction and Mental Health (CAMH). He is also an associate professor in the Department of Psychiatry at the University of Toronto. He received his PhD in Medical Science at the University of Toronto, examining genes for schizophrenia and tardive dyskinesia. He later received his MPH in Epidemiology from Harvard School of Public Health. He studied the genetics of suicide on a postdoctoral fellowship from the American Foundation for Suicide Prevention and a NARSAD Young Investigator Award from the Brain and Behavior Research Foundation. He has been conducting several pharmacogenetic studies in patients with schizophrenia, with a particular focus on the tardive dyskinesia side effects induced by antipsychotic drugs.